First Time Loading...

Globeimmune Inc
OTC:GBIM

Watchlist Manager
Globeimmune Inc Logo
Globeimmune Inc
OTC:GBIM
Watchlist
Price: 0.0002 USD Market Closed
Updated: May 23, 2024

Globeimmune Inc
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Globeimmune Inc
Change in Working Capital Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
Globeimmune Inc
OTC:GBIM
Change in Working Capital
-$4.5m
CAGR 3-Years
24%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Change in Working Capital
$3.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
38%
Gilead Sciences Inc
NASDAQ:GILD
Change in Working Capital
-$2.2B
CAGR 3-Years
-33%
CAGR 5-Years
-3%
CAGR 10-Years
-5%
Amgen Inc
NASDAQ:AMGN
Change in Working Capital
-$422m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-7%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Change in Working Capital
-$275.3m
CAGR 3-Years
-158%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Change in Working Capital
$105.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Globeimmune Inc's Change in Working Capital?
Change in Working Capital
-4.5m USD

Based on the financial report for Dec 31, 2015, Globeimmune Inc's Change in Working Capital amounts to -4.5m USD.

What is Globeimmune Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 5Y
0%

Over the last year, the Change in Working Capital growth was 0%. The average annual Change in Working Capital growth rates for Globeimmune Inc have been 24% over the past three years .